| Literature DB >> 24726010 |
Evelyn Landry1, Celia Pett, Renee Fiorentino, Joseph Ruminjo, Cristina Mattison.
Abstract
BACKGROUND: Reliable, timely information is the foundation of decision making for functioning health systems; the quality of decision making rests on quality data. Routine monitoring, reporting, and review of cesarean section (CS) indications, decision-to-delivery intervals, and partograph use are important elements of quality improvement for maternity services.Entities:
Mesh:
Year: 2014 PMID: 24726010 PMCID: PMC4021100 DOI: 10.1186/1471-2393-14-139
Source DB: PubMed Journal: BMC Pregnancy Childbirth ISSN: 1471-2393 Impact factor: 3.007
Expansion of CS indications from AMDD tool to Fistula Care tool and final recoding
| Obstructed labor (including failed trial of labor, deformed pelvis) | • Obstructed labor | |
| • Failed trial of labor | ||
| • Deformed pelvis | ||
| Uterine rupture | • Uterine rupture | |
| Major antepartum hemorrhage & placenta previa (grade 3 or 4) | • Major antepartum hemorrhage & placenta previa (grade 3 or 4) | Placenta previa |
| Cephalopelvic disproportion (CPD) | • Cephalopelvic disproportion (CPD) | CPD (listed with prolonged labor) |
| Failure to progress in labor, including prolonged labor | • Failure to progress in labor | Prolonged labor (listed with CPD) |
| • Prolonged labor | ||
| Failed induction | • Failed induction | Failed induction |
| Previous CS | • Previous CS | Previous scar |
| • Uterine scar from other previous surgery | ||
| Genitourinary fistula or third-degree tear repair | • Vesico-vaginal fistula postrepair | Vesico-vaginal fistula |
| • Vesico-vaginal fistula | ||
| Antepartum hemorrhage (excluding those for absolute indications and including abruptio placentae) | • Antepartum hemorrhage (excluding those for absolute indications and including abruptio placentae) | Placenta abruptio |
| Maternal medical diseases (e.g., sickle cell anemia, HIV) | • Maternal medical disease (e.g., sickle cell anemia, HIV) | |
| Severe preeclampsia or eclampsia | • Eclampsia/severe preeclampsia | Eclampsia/severe preeclampsia |
| Psychosocial indications (including maternal request) | • Psychosocial/maternal/family request | Maternal distress |
| Precious pregnancy | • Precious baby | |
| Fetal compromise (including fetal distress; cord prolapse/presentation; and severe intrauterine growth retardation) | • Fetal distress | Fetal distress |
| • Cord prolapse/presentation | Cord prolapse | |
| • Severe intrauterine retardation | ||
| Breech presentation | • Breech presentation | Breech with footling/ malpresentation |
| Multiple gestation | • Multiple gestation | Multiple gestation |
| Malpresentation (including transverse, oblique, and brow) | • Malpresentation (including transverse, oblique, and brow) | Breech with footling/ malpresentation |
| Other/not enough information | • Other^ | Other |
^Other indications include those found in patient records which were not part of the pre-coded options but were recoded to indications on our final list (e.g. big baby to obstructed labor. Data that did not include enough information to enable a clear determination about the indication were coded as “other/not enough information”.
Profile of study sites, 2008
| | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Type of institution | Private | Public | Public | Public | Public | Public | Public | Faith-based | Faith-based |
| Location | Rural | Urban | Urban | Urban | Urban | Urban | Urban | Rural | Rural |
| Total no. of maternity beds/total no. of hospital beds | 80/750 | 20/105 | 30/119 | 24/128 | 36/186 | 36/382 | 2/53 | 34/266 | 50/200 |
| Providers who perform CS | | | | | | | | | |
| X | - | - | X | X | X | X | X | X | |
| - | X | X | X | X | X | X | X | - | |
| No. of deliveries in 2008 | 2,178 | 1,136 | 719 | 1,048 | 1,868 | 1,375 | 4925 | 2,929 | 1,778 |
| No. of CS deliveries in 2008 | 1,068 | 277 | 379 | 269 | 302 | 688 | 324 | 998 | 663 |
| 2008 institutional CS rate | 49% | 24% | 53% | 26% | 16% | 49% | 7% | 34% | 37% |
| No. of CS deliveries reviewed | 350 | 277 | 376 | 269 | 299 | 349 | 324 | 348 | 349 |
| % of patient files found | 100.0%1 | 92.1% | 61.2% | 36.8% | 98.7% | 65.0% | 67.3% | 78.4% | 95.1% |
| Number of key informants from facility interviewed | 8 | 7 | 8 | 8 | 4 | 4 | 3 | 6 | 9 |
1Includes 41 records (11.7%) that were partially found.
Percentage distribution of characteristics of women undergoing CS, by study site
| | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Age 25 years or less | 70.3 | 55.2 | 55.3 | 62.8 | 41.5 | 53.6 | 50.0 | 67.2 | 53.9 |
| Primiparous1 | 57.0 | 35.2 | 33.7 | 45.9 | 28.0 | 35.9 | 33.0 | 34.9 | 37.4 |
| Rural residence2 | 98.6 | 41.2 | 70.5 | 31.6 | 61.2 | 50.7 | 58.0 | 77.6 | 63.0 |
| Previous CS | 12.6 | 11.9 | 26.9 | 12.6 | 16.4 | 15.5 | 12.7 | 43.1 | 30.8 |
| Referred to facility | 0.9 | 12.6 | 38.6 | 51.3 | 66.9 | 88.3 | 56.2 | 10.6 | 22.6 |
1Data missing for more than 10% of cases reviewed at Guinea A.
2Data missing for more than 10% of cases reviewed at Uganda A.
Percentage distribution of partograph use, by study site
| | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Partograph used | 1.4 | 0.0 | 0.0 | 23.8 | 97.3 | 96.8 | 99.4 | 23.9 | 18.3 |
| Partograph completed correctly1 | 20.0 | - | - | 34.4 | 2.1 | 65.1 | 0.2 | 23.9 | 18.3 |
| Partograph action line crossed | 0.0 | - | - | 4.7 | 7.6 | 1.5 | 5.0 | - | 46.9 |
1The partograph was assessed as completed correctly if the responses to all nine questions on the checklist were yes: 1) first cervical dilatation charted correctly on alert line; 2) cervical dilation plotted at least every 4 hours; 3) descent of presenting part checked and recorded during labor; 4) contractions assessed and recorded at least half hourly when in active labor; 5) state of membranes assessed and if ruptured, color of liquor recorded; 6) fetal heart rate recorded at least half hourly during labor; 7) mother’s blood pressure checked and recorded at time of admission and during labor; 8) mother’s pulse checked and recorded at admission and during labor; 9) documentation of augmentation or other medication in labor.
Percentage distribution of primary CS indication, by study site
| Obstructed labor (including failed trial of labor, deformed pelvis) | 2.0 | 59.2 | 52.7 | 16.4 | 10.4 | 16.0 | 9.3 | 14.9 | 30.9 |
| Failure to progress/prolonged labor | 5.1 | 2.5 | 0.3 | 8.6 | 9.0 | 5.7 | 7.4 | 19.5 | 16.3 |
| Uterine rupture | 0.3 | 7.2 | 11.4 | 10.0 | 20.7 | 9.5 | 14.2 | 0.3 | 0.3 |
| Previous CS | 11.4 | 0.7 | 11.4 | 3.0 | 3.7 | 5.2 | 2.5 | 18.7 | 10.9 |
| Severe preeclampsia or eclampsia | 11.1 | 0.0 | 0.3 | 13.4 | 7.4 | 17.2 | 14.2 | 1.7 | 2.0 |
| Cephalopelvic disproportion | 5.4 | 6.1 | 4.8 | 11.2 | 6.7 | 4.6 | 5.2 | 11.5 | 5.7 |
| Antepartum hemorrhage and grade 3 or 4 placenta previa | 1.4 | 4.7 | 4.0 | 3.7 | 5.4 | 9.7 | 9.6 | 2.3 | 4.6 |
| Antepartum hemorrhage, excluding absolute indications, including abruptio placentae | 1.4 | 8.7 | 0.3 | 5.2 | 0.7 | 6.9 | 5.9 | 2.6 | 0.0 |
| Precious pregnancy* | 2.3 | 0.4 | 0.5 | 0.4 | 2.3 | 0.3 | 0.3 | 0.6 | 2.3 |
| Genitourinary fistula or third-degree tear repair | 0.0 | 0.0 | 1.3 | 0.4 | 2.0 | 0.3 | 1.2 | 0.0 | 2.0 |
| Maternal medical disease^ | 0.3 | 0.0 | 0.0 | 0.0 | 0.3 | 0.3 | 0.6 | 1.1 | 1.4 |
| Failed induction | 0.3 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.3 | 0.0 | 1.4 |
| Psychosocial, including maternal request | 0.0 | 0.0 | 0.0 | 0.0 | 0.3 | 0.0 | 0.0 | 0.0 | 0.3 |
| Fetal compromise (fetal distress, including cord prolapse/presentation, severe intrauterine growth retardation) | 18.3 | 5.1 | 7.2 | 12.3 | 10.0 | 6.0 | 16.4 | 14.9 | 7.2 |
| Malpresentation (including transverse, oblique, brow) | 2.0 | 4.3 | 4.8 | 4.8 | 12.4 | 10.9 | 9.6 | 5.5 | 10.6 |
| Breech presentation | 4.6 | 0.0 | 0.5 | 5.6 | 3.0 | 2.3 | 0.9 | 3.7 | 1.7 |
| Multiple gestation | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.9 | 0.3 | 1.7 | 0.3 |
*Precious pregnancy is defined as a pregnancy coming after a series of pregnancy losses, such as miscarriages or still births.
^Pre-existing conditions, such as cardiac disease or co-morbidities, such as HIV. While preexisting hypertension predisposes to preeclampsia/toxemia and eclampsia, these conditions are excluded from the category, because they are pregnancy-specific.
Percentage distribution of records found with information on the timing of key events and administration of prophylactic antibiotics, by study site
| | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Time of admission | 82.9 | 19.5 | 1.6% | 51.7 | 92.3 | 90.5 | 96.0 | NA | 50.4 |
| Time of first examination | 4.6 | 0.4 | 0.3 | 5.6 | 59.9 | 75.1 | 67.6 | NA | 59.0 |
| Time decision was made to do CS | 5.1 | 0.4 | 0.0 | 6.7 | 2.7 | 3.4 | 27.8 | NA | 50.9 |
| Time of skin incision | 0.0 | 0.0 | 66.5 | 34.2 | 2.3 | 0.0 | 1.9 | 0.0 | 0.0 |
| Time of birth | 99.1 | 72.9 | 67.0 | 75.5 | 96.3 | 91.7 | 98.8 | NA | 88.0 |
| Records with surgical consent form | 87.4 | 0.0 | 0.3 | 0.0 | 0.0 | 0.0 | 0.0 | NA | 92.8 |
| Prophylactic antibiotics administered | 88.3 | 97.8 | 98.6 | 35.7 | 97.0 | 63.6 | 67.0 | 85.3 | 85.7 |
NA = not available. The data collection form was modified to collect this information only after the study was completed at this site.
Percentage distribution of maternal and fetal outcomes, by study site
| | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| | | | | | | | | | |
| Maternal death | 0.0 | 0.4 | 3.2 | 0.7 | 3.3 | 2.6 | 2.8 | 0.0 | 0.9 |
| No information on maternal outcome | 11.4 | 0.7 | 2.5 | 0.4 | 0.3 | 5.4 | 25.0 | 23.9 | 6.0 |
| | | | | | | | | | |
| Born alive | 86.6 | 74.4 | 72.1 | 81.4 | 65.2 | 69.6 | 65.4 | 84.2 | 51.3 |
| Perinatal Death | 1.4 | 23.1 | 24.5 | 18.6 | 34.4 | 30.1 | 34.0 | 4.9 | 8.6 |
| Stillbirth | |||||||||
| Early Neonatal deaths | |||||||||
| Missing information on timing of death | |||||||||
| Missing information on birth outcome | 12.0 | 2.5 | 3.5 | 0.0 | 0.3 | 0.3 | 0.6 | 10.9 | 40.1 |